��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
愛地雅(8933)
月營收
季盈餘
2025/03/01
8.00元 (愛地雅股價)
2025/03/01
14.97% (年增率)
275百萬元 (營收)
愛地雅(8933) 年度營收走勢圖
愛地雅(8933)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/03
275,160
25.96%
239,336
14.97%
743,876
18.56%
114/02
218,443
-12.72%
211,265
3.40%
468,716
20.77%
114/01
250,273
-24.25%
176,848
41.52%
250,273
41.52%
113/12
330,383
118.05%
265,344
24.51%
2,650,435
-27.48%
113/11
151,516
-42.18%
267,827
-43.43%
2,320,052
-31.55%
113/10
262,044
81.24%
296,027
-11.48%
2,168,536
-30.53%
113/09
144,584
-30.64%
387,198
-62.66%
1,906,492
-32.52%
113/08
208,449
0.95%
341,639
-38.99%
1,761,908
-27.74%
113/07
206,487
-25.74%
194,264
6.29%
1,553,459
-25.90%
113/06
278,070
19.37%
210,036
32.39%
1,346,972
-29.19%
113/05
232,940
11.71%
342,164
-31.92%
1,068,902
-36.83%
113/04
208,513
-12.88%
306,850
-32.05%
835,962
-38.08%
113/03
239,336
13.29%
390,563
-38.72%
627,449
-39.85%
113/02
211,265
19.46%
311,352
-32.15%
388,113
-40.53%
113/01
176,848
-33.35%
341,289
-48.18%
176,848
-48.18%
112/12
265,344
-0.93%
557,691
-52.42%
3,654,553
-34.64%
112/11
267,827
-9.53%
496,854
-46.10%
3,389,209
-32.67%
112/10
296,027
-23.55%
412,560
-28.25%
3,121,382
-31.20%
112/09
387,198
13.34%
655,336
-40.92%
2,825,355
-31.49%
112/08
341,639
75.86%
583,551
-41.46%
2,438,157
-29.71%
112/07
194,264
-7.51%
456,070
-57.40%
2,096,518
-27.33%
112/06
210,036
-38.62%
478,220
-56.08%
1,902,254
-21.69%
112/05
342,164
11.51%
407,211
-15.97%
1,692,218
-13.26%
112/04
306,850
-21.43%
412,389
-25.59%
1,350,054
-12.54%
112/03
390,563
25.44%
462,327
-15.52%
1,043,204
-7.78%
112/02
311,352
-8.77%
329,594
-5.53%
652,641
-2.43%
112/01
341,289
-38.80%
339,318
0.58%
341,289
0.58%
111/12
557,691
12.24%
475,402
17.31%
5,591,120
21.19%
111/11
496,854
20.43%
477,142
4.13%
5,033,429
21.64%
111/10
412,560
-37.05%
442,425
-6.75%
4,536,576
23.92%
111/09
655,336
12.30%
477,255
37.31%
4,124,016
28.13%
111/08
583,551
27.95%
394,007
48.11%
3,468,680
26.53%
111/07
456,070
-4.63%
373,393
22.14%
2,885,129
22.91%
111/06
478,220
17.44%
388,736
23.02%
2,429,059
23.06%
111/05
407,211
-1.26%
354,983
14.71%
1,950,839
23.07%
111/04
412,389
-10.80%
315,209
30.83%
1,543,628
25.48%
111/03
462,327
40.27%
342,766
34.88%
1,131,239
23.64%
111/02
329,594
-2.87%
668,912
111/01
339,318
-28.63%
339,318
110/12
475,402
-0.36%
4,613,524
110/11
477,142
7.85%
4,138,122
110/10
442,425
-7.30%
3,660,980
110/09
477,255
21.13%
3,218,555
110/08
394,007
5.52%
2,741,300
110/07
373,393
-3.95%
2,347,293
110/06
388,736
9.51%
1,973,900
110/05
354,983
12.62%
1,585,163
110/04
315,209
-8.04%
1,230,180
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
